Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | TK1 | P04183 | 2/20 | 0.32 |
| ▸ | TK2 | O00142 | 1/20 | 0.32 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.32 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13169197 | 0.87 | TK1 (0.43) | LMNASMN1; SMN2ALOX12ADRA1ATK1 | |
| SCHEMBL15459905 | 0.73 | LMNA (0.48) | LMNASMN1; SMN2ALOX12ADRA1ATK1 | |
| SCHEMBL16234376 | 0.73 | TK1 (0.48) | LMNASMN1; SMN2ALOX12ADRA1ATK1 | |
| SCHEMBL17732550 | 0.73 | LMNA (0.48) | LMNASMN1; SMN2ALOX12ADRA1ATK1 | |
| SCHEMBL17232106 | 0.72 | LMNA (0.35) | LMNASMN1; SMN2 | |
| SCHEMBL17232090 | 0.72 | TK1 (0.35) | TK1 | |
| SCHEMBL26941474 | 0.72 | LMNA (0.54) | LMNATK1 | |
| SCHEMBL16158115 | 0.72 | TK1 (0.36) | LMNATK1 | |
| SCHEMBL17232091 | 0.72 | LMNA (0.36) | LMNASMN1; SMN2ALOX12ADRA1A | |
| SCHEMBL13949130 | 0.72 | RNASE1 (0.36) | LMNATK1TK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11874280-B2 | Use of divalent metals for enhancement of fluorescent signals | Sony Group Corporation (JP) | 2024-01-16 | — | — | US | disclosed |
| US-20230129481-A1 | ULTRA BRIGHT DIMERIC OR POLYMERIC DYES WITH SPACING LINKER GROUPS | Sony Group Corporation (JP) | 2023-04-27 | — | — | US | disclosed |
| US-9851359-B2 | Ultra bright dimeric or polymeric dyes with spacing linker groups | SONY CORPORATION OF AMERICA (US) | 2017-12-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230129481-A1 | ULTRA BRIGHT DIMERIC OR POLYMERIC DYES WITH SPACING LINKER GROUPS | IK, MTCL3, RRM1 | LMNA 201/4885SMN1; SMN2 1247/4885ALOX12 4443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.